Table 8 An assessment of the urinalysis changes affected by the 90-day oral administration of 23%-GNANA, a test substance to the male and female rats (n=10)

Tests** Result Severity Groups (mg/kg/day)
Male Female
G1% G2 G3 G4 G1 G2 G3 G4
0 1,250 2,500 5,000 0 1,250 2,500 5,000
GLU - 0 5 5 5 5 5 5 5 5
BIL - 0 5 5 5 5 5 5 5 5
KET - 0 5 1 4 4 5 5 5 5
+/- 1 1 1 1
1+ 2 3
SG ≤1.005 0 1
1.010 1 4 4 4
1.015 2 1* 1* 1* 1 4* 3*
1.020 3 3* 2* 2* 1* 1*
pH 1.025 4 1 2 2 1
1.030 5 1
≤7.0 1 1
7.5 2 2 2 3 4 1 1 2 1
8.0 3 3 2 1 1 1 2 3 3
PRO 8.5 4 1* 3 2 1
- 0 1 4 2 3
+/- 1 3 1 1 1 3* 1
1+ 2 1 3* 1 1* 3*
2+ 3 2* 3 2 1* 1*
UROa) 3+ 4 1 1
0.2 0 5 5 4 5 5 4 4 4
NIT 1 1 1 1 1 1
OB - 0 5 5 5 5 5 5 5 5
- 0 1 4 4 5 5 5 5 5
+/- 1 3 1 1
1+ 2 1
LEU - 0 4 3 2
+/- 1 3 1 1 2 1 1 4
1+ 2 1 3 1 2 1 2
2+ 3 1 1 2 1 1
3+ 4 1 1
No. of animals 5 5 5 5 5 5 5 5
a) The unit of urobilinogen is ehrlich unit/dL, *: Represents a significant difference at p<0.05 level compared with the vehicle control, **: GLU: Glucose, BIL: Bilirubin, KET: Ketone body, SG: Specific gravity, PRO: Protein, URO: Urobilinogen, NIT: Nitrite, OB: Occult blood, LEU: Leukocyte, %: Control group (G1), Low-dose group (G2: 1,250 mg/10 mL/day), Medium-dose group (G3: 2,500 mg/10 mL/day), High -dose group (G4: 5,000 mg/10 mL/day)